Literature DB >> 30467097

Inflammasome and cytokine expression profiling in experimental periodontitis in the integrin β6 null mouse.

Jiarui Bi1, Jiayin Dai2, Leeni Koivisto1, Milla Larjava1, Liangjia Bi3, Lari Häkkinen1, Hannu Larjava4.   

Abstract

Epithelial αvβ6 integrin participates in immune surveillance in many organs, including the gastrointestinal track. Expression of αvβ6 integrin is reduced in the junctional epithelium of the gingiva in periodontal diseases, and mutations in the ITGB6 gene are associated with these diseases in humans and mice. The aim of this study was to unravel potential differences in the inflammatory responses in the periodontal tissues of FVB wild-type (WT) and β6 integrin-null (Itgb6-/-) mice, using a ligature-induced periodontitis model and assessing inflammation, bone loss and expression profiles of 34 genes associated with periodontal disease. Using micro-CT and histology, we demonstrated more advanced inflammation and bone loss in the control and ligatured Itgb6-/- mice compared to the WT animals. Neutrophil and macrophage marker genes were significantly upregulated by ligation in both WT and Itgb6-/- mice while the expression of T-cell and B-cell markers was downregulated, suggesting acute-type of inflammation. Expression of inflammasome NLRP3-related genes Nlpr3 and Il1b was also significantly increased in both groups. However, the expression of Il18 was significantly lower in non-ligatured Itgb6-/- mice than in the WT mice and was further downregulated in both groups by the ligatures. IL-18 mediates many effects of the AIM2 inflammasome, including regulation of the microbiome. Interestingly, expression of Aim2 was significantly lower in both control and ligatured Itgb6-/- mice than in WT animals. Overall, ligature-induced periodontitis was associated with increased expression of pro-inflammatory cytokines, chemokines and osteoclastogenic regulatory molecules. Another significant difference between the Itgb6-/- and WT mice was that mRNA expression of the anti-inflammatory cytokine IL-10 was increased in ligatured WT mice but reduced in the Itgb6-/- mice. In conclusion, αvβ6 integrin in junctional epithelium of the gingiva appears to positively regulate the expression of the AIM2 inflammasome and anti-inflammatory IL-10, thus providing protection against periodontal inflammation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alveolar bone loss; Gingiva; Inflammation; Itgb6(−/−) mouse; Ligature; Periodontal diseases

Mesh:

Substances:

Year:  2018        PMID: 30467097     DOI: 10.1016/j.cyto.2018.11.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  Runx2 deficiency in junctional epithelium of mouse molars decreases the expressions of E-cadherin and junctional adhesion molecule 1.

Authors:  Yuan Tian; Haiyu Mu; Aiqin Wang; Yan Gao; Zhiheng Dong; Yang Zhao; Cong Li; Li Zhang; Yuguang Gao
Journal:  J Mol Histol       Date:  2021-03-24       Impact factor: 2.611

2.  Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats.

Authors:  Yi Zhang; Deshu Zhuang; Yi Zhang; Huiying Lu; Haijiao Zhang; Tingting Li; Liangjia Bi
Journal:  Drug Des Devel Ther       Date:  2020-12-15       Impact factor: 4.162

3.  Altered composition of the oral microbiome in integrin beta 6-deficient mouse.

Authors:  Osamu Uehara; Jiarui Bi; Deshu Zhuang; Leeni Koivisto; Yoshihiro Abiko; Lari Häkkinen; Hannu Larjava
Journal:  J Oral Microbiol       Date:  2022-09-12       Impact factor: 5.833

Review 4.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

5.  Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway.

Authors:  Muyu Yu; Wei Liu; Junxian Li; Junxi Lu; Huijuan Lu; Weiping Jia; Fang Liu
Journal:  Stem Cell Res Ther       Date:  2020-08-12       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.